-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 LieQS/rieVv+CUu2sBSAmdNSKgmroRs/XrK0qPgq9947dOVILdpvu5ITHIRa0Flx
 W+hdVVPnEB4YTLDfwrzjGQ==

<SEC-DOCUMENT>0000921530-04-000621.txt : 20041217
<SEC-HEADER>0000921530-04-000621.hdr.sgml : 20041217
<ACCEPTANCE-DATETIME>20041217170717
ACCESSION NUMBER:		0000921530-04-000621
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20041217
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20041217
DATE AS OF CHANGE:		20041217

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEDICIS PHARMACEUTICAL CORP
		CENTRAL INDEX KEY:			0000859368
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				521574808
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14471
		FILM NUMBER:		041212021

	BUSINESS ADDRESS:	
		STREET 1:		8125 NORTH HAYDEN ROAD
		CITY:			SCOTTSDALE
		STATE:			AZ
		ZIP:			85258
		BUSINESS PHONE:		2125992000

	MAIL ADDRESS:	
		STREET 1:		8125 NORTH HAYDEN ROAD
		CITY:			SCOTTSDALE
		STATE:			AZ
		ZIP:			85258
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>medicis_8k-121704.txt
<TEXT>
================================================================================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15 (d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

       Date of Report (Date of Earliest Event Reported): December 17, 2004

                       MEDICIS PHARMACEUTICAL CORPORATION
             (Exact Name of Registrant as Specified in Its Charter)

           Delaware                      0-18443                52-1574808
(State or Other Jurisdiction of   (Commission File Number)    (IRS Employer
        Incorporation)                                       Identification No.)

8125 North Hayden Road
Scottsdale, Arizona                                                 85258-2463
(Address of Principal                                               (Zip Code)
Executive Offices)

Registrant's telephone number, including area code:             (602) 808-8800

                                       N/A
          -------------------------------------------------------------
          (Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))

================================================================================

<PAGE>

Item 8.01     Other Events.

              Medicis Pharmaceutical Corporation (the "Company") has provided
documents in response to a government inquiry into the Company's marketing and
promotion of Loprox to pediatricians. The Company is cooperating with the
government but has no further information at this time regarding this matter.


<PAGE>

                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                         MEDICIS PHARMACEUTICAL CORPORATION
                                         (Registrant)


Date: December 17, 2004                  /s/ Mark A. Prygocki, Sr.
                                         ---------------------------------------
                                         Name:      Mark A. Prygocki, Sr.
                                         Title:     Executive Vice President,
                                                    Chief Financial Officer,
                                                    Corporate Secretary and
                                                    Treasurer

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----